US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hemostemix Inc

0.0890

+0.008911.07%

Volume:4.50K

Turnover:400.50

Market Cap:12.55M

PE:-5.43

High:0.0890

Open:0.0890

Low:0.0890

Close:0.0801

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Hemostemix Inc

Exchange:

OTCQB

Establishment Date:

- -

Employees:

- -

Office Location:

707-7th Avenue SW,Suite 1150,Calgary,Alberta,Canada

Website:

http://www.hemostemix.com

Zip Code:

T2P 3H6

Phone:

- -

Fax:

- -

Introduction:

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia in Canada and the United States. The company is also developing various types of cell products, such as synergetic cell populations, neural cell precursors, and cardiomyocyte cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HMTXF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HMTXF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HMTXF\",,,,,undefined,":{"symbol":"HMTXF","market":"US","secType":"STK","nameCN":"Hemostemix Inc","latestPrice":0.089,"timestamp":1748894400000,"preClose":0.080131,"halted":3,"volume":4500,"delay":15,"floatShares":141000000,"shares":141000000,"eps":-0.016388,"marketStatus":"Halted","change":0.008869,"latestTime":"06-02 16:00:00 EDT Delay","open":0.089,"high":0.089,"low":0.089,"amount":400.5,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.016388,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1748957400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.089,"volumeRatio":0.030156249589246748},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HMTXF\",,,,,undefined,":{"symbol":"HMTXF","floatShares":141000000,"roa":"-247.75%","roe":"441.27%","lyrEps":-0.022965,"volumeRatio":0.030156249589246748,"shares":141000000,"dividePrice":0,"high":0.089,"amplitude":0,"preClose":0.080131,"low":0.089,"week52Low":0.024,"pbRate":"-2.31","week52High":0.285,"institutionHeld":0,"latestPrice":0.089,"eps":-0.016388,"divideRate":0,"volume":4500,"delay":15,"ttmEps":-0.016388,"open":0.089,"prevYearClose":0.07366,"prevWeekClose":0.0801,"prevMonthClose":0.0801,"prevQuarterClose":0.054,"fiveDayClose":0.0867,"twentyDayClose":0.065,"sixtyDayClose":0.1013},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":240304994,"address":"707-7th Avenue SW,Suite 1150,Calgary,Alberta,Canada","zipCode":"T2P 3H6"},"stockCompanyDetail":{"websiteUrl":"http://www.hemostemix.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.7043},{"period":"6month","weight":-0.722},{"period":"1year","weight":-0.8284},{"period":"ytd","weight":-0.7377}],"description":"Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia in Canada and the United States. The company is also developing various types of cell products, such as synergetic cell populations, neural cell precursors, and cardiomyocyte cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.","exchange":"OTCQB","name":"Hemostemix Inc","nameEN":"Hemostemix Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"HMTXF\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HMTXF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-04-29","symbol":"HMTXF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714363200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-29","symbol":"HMTXF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1701234000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-09-26","symbol":"HMTXF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1664164800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-12-30","symbol":"HMTXF","defaultRemindTime":1609338600000,"type":"split","dateTimestamp":1609304400000,"forFactor":20,"toFactor":1,"ratio":20}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HMTXF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HMTXF\",market:\"US\",delay:false,,,undefined,":{}}}